AGP Konstas, D Mikropoulos, AT Dimopoulos, … - British Journal of Ophthalmology, 2008 - bjo.bmj.com Methods: A prospective, observer-masked, placebo-controlled, crossover,
comparison. Consecutive adults with primary open-angle or exfoliative glaucoma
who exhibit a mean baseline IOP >21 mm Hg on latanoprost monotherapy were ... Cited by 1 - Related articles - All 3 versions
- ►oxfordjournals.org I Sabnani, MJ Zucker, ED Rosenstein, DA … - Rheumatology, 2008 - Br Soc Rheumatology Objective. Scleroderma-related interstitial lung disease (SSc-ILD) has limited
therapeutic options due to unclear pathogenesis. Recently, PDGF receptor (PDGFR)
amplification has been postulated to cause fibrosis. We hypothesized that a ... Cited by 5 - Related articles - All 6 versions
AGP Konstas, VP Kozobolis, N Lallos, E … - Eye, 2004 - nature.com Results In 33 patients, the mean diurnal IOP (0800–2000, measured every 2 h)
for latanoprost/timolol fixed combination was 17.3 2.2 mmHg and for
dorzolamide/timolol, the fixed combination was 17.0 2.0 mmHg (P=0.36). ... Related articles
M Forster, S Kaye, A Oza, I Sklenar, A Johri … - Clinical Cancer Research, 2007 - AACR Results: Of the 37 patients enrolled, the majority previously received taxanes
(81%) and/or platinum-containing drugs (97.3%). The maximum tolerated dose (MTD)
of patupilone with carboplatin AUC 6 was 4.8 mg/m 2 ; additional patients ... Cited by 9 - Related articles - BL Direct - All 6 versions
- ►oxfordjournals.org M Von Mehren, RJ Schilder, JD Cheng, E … - Annals of Oncology, 2008 - Eur Soc Med Oncology Results: The MTD of trabectedin was 1.1 mg/m 2 . Drug-related grade 3 and 4
toxic effects were neutropenia (31%) and elevated transaminases (31%). Six
patients responded (one CR, five partial responses), with an overall ... Cited by 9 - Related articles - All 5 versions
AGP Konstas, P Papapanos, I Tersis, D … - Ophthalmology, 2003 - Elsevier To evaluate the efficacy and safety of commercially available latanoprost 0.005%
given every evening versus timolol 0.5% and dorzolamide 2% fixed combination
(TDFC) given twice daily to white Greeks with primary open-angle glaucoma ... Cited by 42 - Related articles - All 14 versions
B Cvenkel, JA Stewart, LA Nelson, WC … - Current Eye Research, 2008 - informahealthcare.com Purpose: The efficacy of dorzolamide/timolol fixed combination (DTFC) versus
latanoprost/timolol fixed combination (LTFC) in open-angle glaucoma or ocular
hypertensive patients. Methods: Patients were randomized to DTFC or LTFC ... Cited by 3 - Related articles - BL Direct - All 4 versions
SL Smith, CA Pruitt, CS Sine, AC Hudgins, … - Acta Ophthalmologica Scandinavica, 1999 - ncbi.nlm.nih.gov PURPOSE: To evaluate the use of latanoprost 0.005% given once daily to simplify
a patient's glaucoma medical regimen. METHODS: We reviewed 527 charts of which
we included 61 patients (61 eyes) with either ocular hypertension or ... Cited by 9 - Related articles - BL Direct - All 5 versions
[CITATION] Glaucoma treatment and diagnostic trends
